Saturday, 6 July 2013

A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer (IXAMPLE2)


You must be a healthcare professional to view this section of the site. Login to view more.



share this page with othersSorry, I could not read the content fromt this page.

View the original article here

Posted by at
Labels: , , , , , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)